课题基金 / 基金详情

SALMONELLA HIJACKING OF STAT3 AND CONSEQUENCES FOR DISEASE

SALMONELLA HIJACKING OF STAT3 AND CONSEQUENCES FOR DISEASE
沙门氏菌劫持 STAT3 及其疾病后果
批准号:
9806916
负责人:
Dennis Chun-Yone Ko
金额:
$23.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-21 至 2021-05-31

项目摘要

项目成果

Dennis Chun-Yone Ko的其他基金

相似基金

相关文献

中文摘要
翻译
据估计,沙门氏菌导致1.5亿例胃肠炎和2500万例侵袭性疾病 (肠热病和非伤寒菌血症),每年导致30万人死亡。沙门氏菌操纵 通过分泌效应器蛋白的多种宿主细胞途径,但大多数效应器的分子功能, 尤其是在动物和人类中,仍然知之甚少。全面描述沙门氏菌如何 效应器的功能和它们所针对的途径需要了解效应器如何影响感染和它们的 对慢性炎症性疾病的长期后果,如炎症性肠病(IBD)。IBD是 一种免疫介导的疾病以及IBD是否受到先前沙门氏菌感染的影响尚不清楚, 来自流行病学和老鼠研究的相互矛盾的证据。为了了解沙门氏菌的急性程度 感染可能影响长期的免疫调节,需要研究来确定沙门氏菌的特异性 效应器针对宿主免疫调节途径,这些变化是否在感染后持续,以及这些 变化会调节疾病的风险或严重程度。 通过沙门氏菌血清学的比较基因组学,我们最近发现了一种新的前噬菌体编码型 III分泌型效应物:沙门氏菌抗炎反应激活剂(SARA)。萨拉是唯一的沙门氏菌 效应器被证明是激活STAT3(信号转换器和激活器)的必要条件和充分条件 转录-3),一种调节免疫细胞增殖、发育和自身免疫的关键转录因子 包括IBD在内的各种情况。SARA介导的STAT3操纵在宿主细胞中重新编程转录和 增加小鼠的毒力。我们假设SARA对注射了效应器的细胞既有直接影响,又有 STAT3靶基因(如抗炎细胞因子IL-10)可能导致的次要后果 在感染清除后引起持续的变化。因此,此应用程序的目标是 确定SARA在感染期间和感染后如何激活STAT3并影响免疫细胞群。 根据初步数据,我们假设SARA直接结合STAT3和辅因子组装STAT3- 激活平台。该通路的激活可在多种细胞类型中磷酸化STAT3,但其作用机制尚不清楚 哪些细胞是体内的靶点,这种激活在感染期间和感染后的后果是什么。 因此,我们提出了以下具体目标:1)确定SARA如何通过生化途径驱动STAT3的激活 和遗传方法,以及2)确定SARA对免疫细胞群体和长期 对宿主的影响,包括结肠炎的肠道炎症严重程度。在这些项目完成后 AIMS,我们将确定SARA如何调节STAT3信号,以及这些信号事件如何/是否改变 感染期间和感染后的免疫功能。揭示这些机制可能导致新的治疗方法 治疗沙门氏菌病的策略,以及其他依赖STAT3的病理情况,包括 自身免疫性疾病、癌症和其他传染病。
英文摘要
Salmonellae cause an estimated 150 million cases of gastroenteritis and 25 million cases of invasive disease (enteric fever and non-typhoidal bacteremia), leading to 300,000 deaths per year. Salmonella manipulates multiple host cellular pathways through secreted effector proteins, but the molecular functions of most effectors, especially in animals and humans, remain poorly understood. A thorough characterization of how Salmonella effectors function and the pathways they target is required to understand how effectors impact infection and their long-term consequences on chronic inflammatory conditions, such as inflammatory bowel disease (IBD). IBD is an immune-mediated disease and whether IBD is affected by previous Salmonella infection is unclear, with conflicting evidence from both epidemiological and mouse studies. To understand how acute Salmonella infections may impact long-term immune modulation, studies are needed to determine how specific Salmonella effectors target host immune regulatory pathways, whether these changes persist beyond infection, and if these changes modulate risk or severity of disease. Through comparative genomics of Salmonella serovars, we recently identified a novel prophage-encoded Type III secreted effector: Salmonella anti-inflammatory response activator (SarA). SarA is the only Salmonella effector demonstrated to be necessary and sufficient to activate STAT3 (signal transducer and activator of transcription-3), a key transcription factor that regulates immune cell proliferation, development, and autoimmune conditions including IBD. SarA-mediated manipulation of STAT3 reprograms transcription in host cells and increases virulence in mice. We hypothesize SarA has both direct effects on cells injected with the effector and secondary consequences due to STAT3 target genes (such as the anti-inflammatory cytokine IL-10) that may cause persistent changes after infection has cleared. Therefore, the objective of this application is to determine how SarA activates STAT3 and affects immune cell populations during and after infection. Based on preliminary data, we hypothesize that SarA directly binds STAT3 and cofactors to assemble a STAT3- activating platform. Activation of this pathway phosphorylates STAT3 in multiple cell types, but it is unknown which cells are targeted in vivo and what the consequences of this activation are during and after infection. Therefore, we propose Specific Aims to 1) determine how SarA drives STAT3 activation through biochemical and genetic approaches and 2) determine the effects of SarA on immune cell populations and long-term consequences for the host, including severity of intestinal inflammation in colitis. Following completion of these aims, we will have determined how SarA mediates STAT3 signaling and how/if these signaling events alter immune function during and after infection. Revealing these mechanisms could lead to new therapeutic strategies for treating salmonellosis, as well as other STAT3-dependent pathological conditions including autoimmune diseases, cancer, and other infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Contributors to the Impact of Sex on Heterogeneity in Flu Infection
  • 批准号:
    10869787
  • 项目类别:
  • 资助金额:
    $16.14万
  • 财政年份:
    2023
  • 负责人:
    Dennis Chun-Yone Ko
  • 依托单位:
Genetic Contributors to the Impact of Sex on Heterogeneity in Flu Infection
  • 批准号:
    10663342
  • 项目类别:
  • 资助金额:
    $51.72万
  • 财政年份:
    2022
  • 负责人:
    Dennis Chun-Yone Ko
  • 依托单位:
Genetic Contributors to the Impact of Sex on Heterogeneity in Flu Infection
  • 批准号:
    10483384
  • 项目类别:
  • 资助金额:
    $54.9万
  • 财政年份:
    2022
  • 负责人:
    Dennis Chun-Yone Ko
  • 依托单位:
Human Genetic Variation Regulating Transcriptional Response and Cellular Susceptibility to Influenza
  • 批准号:
    10366027
  • 项目类别:
  • 资助金额:
    $23.56万
  • 财政年份:
    2021
  • 负责人:
    Dennis Chun-Yone Ko
  • 依托单位:
海外基金